MO126CLINICAL AND BIOMARKER CHARACTERISTICS OF PATIENTS WITH C3G OR IC-MPGN ENROLLED IN TWO PHASE II STUDIES INVESTIGATING THE FACTOR D INHIBITOR DANICOPAN*
Carla Nester, Steven D. Podos, Jonathan Hogan, Gerald B. Appel, Andrew S. Bomback, Koen Bouman, Terry Cook, Erica Daina, Bradley P. Dixon, Craig B. Langman, Liz Lightstone, Jane A. Thanassi, Kara Rice, Mingjun Huang, Samir M. Parikh, Matthew C. Pickering, John Sperati, Howard Trachtman, James A. Tumlin, Jack F.M. Wetzels, Giuseppe Remuzzi (2021). MO126CLINICAL AND BIOMARKER CHARACTERISTICS OF PATIENTS WITH C3G OR IC-MPGN ENROLLED IN TWO PHASE II STUDIES INVESTIGATING THE FACTOR D INHIBITOR DANICOPAN*. , 36(Supplement_1), DOI: https://doi.org/10.1093/ndt/gfab092.004.
